Case Control Study
Copyright ©The Author(s) 2021.
World J Gastroenterol. Jan 14, 2021; 27(2): 162-175
Published online Jan 14, 2021. doi: 10.3748/wjg.v27.i2.162
Table 2 Correlation coefficients between 10-7G value and clinical parameters in ulcerative colitis and Crohn’s disease patients
UC
CD
rsP valuenrsP valuen
Alb-0.1820.25441-0.376a0.01442
ALT-0.2140.33922-0.1480.5122
ALP0.4530.052190.3290.16919
T-Bil-0.4190.05921-0.0810.72821
γ-GTP-0.060.801200.3920.07921
CRP0.525a0.0003440.595a< 0.000144
Hb-0.308a0.041944-0.2870.07240
Ht-0.3040.06438-0.2610.09143
WBC0.2890.057440.2150.17741
Plt0.060.712400.1450.38738
Mayo0.435a0.03823
CDAI0.1340.39243

  • Citation: Motooka K, Morishita K, Ito N, Shinzaki S, Tashiro T, Nojima S, Shimizu K, Date M, Sakata N, Yamada M, Takamatsu S, Kamada Y, Iijima H, Mizushima T, Morii E, Takehara T, Miyoshi E. Detection of fucosylated haptoglobin using the 10-7G antibody as a biomarker for evaluating endoscopic remission in ulcerative colitis. World J Gastroenterol 2021; 27(2): 162-175
  • URL: https://www.wjgnet.com/1007-9327/full/v27/i2/162.htm
  • DOI: https://dx.doi.org/10.3748/wjg.v27.i2.162